Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection

被引:38
|
作者
Zheng, Hongmei [1 ]
Zhan, Yuting [1 ]
Zhang, Yuting [1 ]
Lin, Sile [1 ]
Lu, Junmi [1 ]
Yang, Yang [1 ]
Wen, Qiuyuan [1 ]
Fan, Songqing [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China
来源
CANCER MEDICINE | 2019年 / 8卷 / 16期
基金
中国国家自然科学基金;
关键词
biomarker; G3BP1; nonsmall cell lung cancer; p-AKT; prognosis; YB1; EPITHELIAL-MESENCHYMAL TRANSITION; GTPASE-ACTIVATING PROTEIN; POTENTIAL TARGETS; BINDING PROTEIN-1; SIGNALING PATHWAY; BREAST-CANCER; YB-1; PROMOTES; CARCINOMA; OVEREXPRESSION;
D O I
10.1002/cam4.2579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose G3BP1 is an RNA-binding protein and plays roles in regulating signaling pathway. YB-1 is a DNA/RNA binding protein encoded by YBX1 gene. Phosphorylated AKT (p-AKT) acts as a pivotal molecule in PI3K/AKT pathway. YB-1 drives stress granules (SGs) formation by activating G3BP1 translation under diverse conditions. SGs are involved in many different metabolic and signaling pathways which may include PI3K/AKT/mTOR. So far, there has been no report on the relationship between expression of G3BP1, p-AKT, and YB1 and clinicopathological features/prognosis in surgically resected nonsmall cell lung cancer (NSCLC) patients. Methods In this study, data from TCGA (The Cancer Genome Atlas) were downloaded to investigate the mRNA expression of G3BP1 and YB1 (YBX1) and their correlation in NSCLC. Also, expression of G3BP1, YB1, and p-AKT proteins was studied using immunohistochemistry in tissue microarrays of NSCLC and in noncancerous lung tissues. Results We found that the mRNA expression of G3BP1 and YB1 was higher in NSCLC tissues (both P .05), and G3BP1 was positively correlated with YB1 in mRNA level (r = .399, P < .001). Also, expression of G3BP1, YB1, and p-AKT proteins was higher in NSCLC tissues (all P < .05). And higher expression of G3BP1 and YB1 proteins was seen in patients with clinical stage II and III compared with stage I (both P < .05). Besides, expression of G3BP1 protein had a positive correlation with YB1 and p-AKT (both P < .05). Moreover, overall survival was shorter in patients with overexpression of G3BP1, YB1, and p-AKT proteins (all P < .05). Multivariate analysis confirmed that overexpression of G3BP1 protein was an independent poorer prognostic factor for NSCLC patients (P = .039). Conclusion G3BP1 may play a crucial role in activating PI3K/AKT/mTOR pathway. G3BP1 might be served as a novel prognostic biomarker for surgically resected NSCLC patients, which afforded new insights into the study on the mechanism and therapy of NSCLC.
引用
收藏
页码:6894 / 6903
页数:10
相关论文
共 26 条
  • [21] An integrated biomarker of PD-L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases
    Li, Lin-Lin
    Zhou, De-Xiang
    Lu, Ming
    Zhou, Dong
    Lin, Xiao-Feng
    Chen, Yu
    Yin, Kai
    Feng, Hui-Bo
    Guo, Wei-Bang
    Xie, Zhi
    Yan, Wen-Qing
    Lv, Zhi-Yi
    Lu, Dan-Xia
    Zhang, Shui-Lian
    Zhang, Xu-Chao
    THORACIC CANCER, 2022, 13 (13) : 1948 - 1960
  • [22] ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients
    Zhou, Haijing
    Cai, Lin
    Zhang, Xiupeng
    Li, Ailin
    Miao, Yuan
    Li, Qingchang
    Qiu, Xueshan
    Wang, Enhua
    LABORATORY INVESTIGATION, 2018, 98 (05) : 670 - 681
  • [23] High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2
    Miao, Jidong
    Gao, Yang
    Guan, Wenqiang
    Yu, Xiaolin
    Wang, Yong
    Jiang, Ping
    Yang, Lili
    Xu, Lun
    You, Wei
    GENES & GENOMICS, 2023, 45 (05) : 611 - 625
  • [24] High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2
    Jidong Miao
    Yang Gao
    Wenqiang Guan
    Xiaolin Yu
    Yong Wang
    Ping Jiang
    Lili Yang
    Lun Xu
    Wei You
    Genes & Genomics, 2023, 45 : 611 - 625
  • [25] Up regulation of PD-L1 on peripheral blood CD3+T cells predicts poor prognosis in patients with non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR) inhibitors
    Meniawy, T.
    Lake, R.
    McDonnell, A.
    Millward, M.
    Nowak, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S47 - S47
  • [26] Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins PHD1 and PHD2 but Not PHD3 Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer
    Koren, Ana
    Rijavec, Matija
    Krumpestar, Tomaz
    Kern, Izidor
    Sadikov, Aleksander
    Cufer, Tanja
    Korosec, Peter
    CANCERS, 2021, 13 (10)